Abstract
Response-Adapted Lenalidomide Maintenance in Newly Diagnosed, Transplant-Eligible Multiple Myeloma: Results from the Multicenter Phase III GMMG-MM5 Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have